Keyphrases
Marfan Syndrome
100%
Swine Model
66%
Marfan
28%
Valve Incompetence
28%
Body Structure
14%
Lens Dislocation
14%
Nonsurgical Approach
14%
Connective Tissue Disease
14%
Scoliosis
14%
Mitral Valve Prolapse
14%
Successful Development
14%
Non-surgical Methods
14%
Surgical Approach
14%
AT1 Blocker
14%
Ascending Aorta
14%
Adult Form
14%
Fibrillin-1 (FBN1)
14%
Myopia
14%
FBN1 Gene
14%
Aortic Dilation
14%
Thin Body
14%
Aortic Dilatation
14%
Mouse Model
9%
Elastin
9%
Cardiovascular System
9%
Large Animal Model
9%
Autosomal Dominant
9%
Transgenic pig
9%
Mouse Data
9%
Angiotensin II Type 1 Receptor (AT1R)
9%
Medical Challenges
9%
Genetically Modified Organisms
9%
Medicine and Dentistry
Marfan Syndrome
100%
Surgical Approach
28%
Ascending Aorta
14%
Body Structure
14%
Surgical Procedure
14%
Angiotensin 1 Receptor Antagonist
14%
Mitral Insufficiency
14%
Connective Tissue Disease
14%
Mitral Valve Prolapse
14%
Scoliosis
14%
Skeleton
14%
Lens Luxation
14%
Autosomal Dominant Inheritance
9%
Cardiovascular System
9%
Childbirth
9%
Limb
9%
Angiotensin II
9%
Cardiovascular System
9%
Disease
9%
Elastin
9%
Pharmacology, Toxicology and Pharmaceutical Science
Marfan Syndrome
100%
Porcine Model
66%
Mouse
19%
Lens Luxation
14%
Connective Tissue Disease
14%
Transgenic Pig
14%
Mitral Valve Regurgitation
14%
Elastin
14%
Angiotensin 1 Receptor Antagonist
14%
Scoliosis
14%
Mitral Valve Prolapse
14%
Transgenic Animal
9%
Disease
9%
Angiotensin II
9%
Mouse Model
9%